Simplex Trading’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,162
| Closed | -$14K | – | 2384 |
|
|
2025
Q1 | $14K | Sell |
4,162
-13,657
| -77% | -$45.9K | ﹤0.01% | 1662 |
|
|
2024
Q4 | $67K | Sell |
17,819
-93,909
| -84% | -$353K | ﹤0.01% | 1295 |
|
|
2024
Q3 | $361K | Sell |
111,728
-108,789
| -49% | -$352K | ﹤0.01% | 711 |
|
|
2024
Q2 | $418K | Buy |
220,517
+138,410
| +169% | +$262K | ﹤0.01% | 683 |
|
|
2024
Q1 | $233K | Sell |
82,107
-47,315
| -37% | -$134K | ﹤0.01% | 925 |
|
|
2023
Q4 | $1.91M | Buy |
129,422
+106,870
| +474% | +$1.57M | ﹤0.01% | 290 |
|
|
2023
Q3 | $412K | Sell |
22,552
-20,503
| -48% | -$375K | ﹤0.01% | 593 |
|
|
2023
Q2 | $928K | Buy |
+43,055
| New | +$928K | ﹤0.01% | 393 |
|
|
2023
Q1 | – | Sell |
-24,248
| Closed | -$895K | – | 2260 |
|
|
2022
Q4 | $895K | Sell |
24,248
-92,356
| -79% | -$3.41M | ﹤0.01% | 341 |
|
|
2022
Q3 | $3.28M | Sell |
116,604
-41,486
| -26% | -$1.17M | ﹤0.01% | 149 |
|
|
2022
Q2 | $3.04M | Buy |
158,090
+152,892
| +2,941% | +$2.94M | ﹤0.01% | 158 |
|
|
2022
Q1 | $66K | Buy |
+5,198
| New | +$66K | ﹤0.01% | 1590 |
|